In the area of dystonia treatment, we continue to provide botulinum toxin injections to our patients while training physicians to perform these injections. For patients with blepharospasm, we have been evaluating the efficacy of various types of non-invasive brain stimulation. Low frequency repetitive TMS, theta burst stimulation and tDCS have been compared. We are also conducting therapeutic trials in blepharospasm of a cream that has an action similar to botulinum toxin. Past studies from our group have shown that certain rehabilitation techniques, such as motor training and sensory training can be therapeutic. We are trying to develop other methods of rehabilitation that might be more efficacious. New treatments are needed for essential tremor. One promising agent is 1-octanol and its metabolite, 1-octanoic acid, which we continue to develop. We have characterized the pharmacokinetics and compared the efficacy of different formulations in a dose escalation and cross-over study in patients with essential tremor. Most recently, we have been conducting trials with 1-octanoic acid, seeking the maximum tolerated dose.

Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2013
Total Cost
$194,007
Indirect Cost
City
State
Country
Zip Code
Vanegas-Arroyave, Nora; Lauro, Peter M; Huang, Ling et al. (2016) Tractography patterns of subthalamic nucleus deep brain stimulation. Brain 139:1200-10
Voller, Bernhard; Lines, Emily; McCrossin, Gayle et al. (2016) Dose-escalation study of octanoic acid in patients with essential tremor. J Clin Invest 126:1451-7
Rossi, P Justin; Gunduz, Aysegul; Judy, Jack et al. (2016) Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies. Front Neurosci 10:119
Cho, Hyun Joo; Hallett, Mark (2016) Non-Invasive Brain Stimulation for Treatment of Focal Hand Dystonia: Update and Future Direction. J Mov Disord 9:55-62
Haubenberger, Dietrich; Abbruzzese, Giovanni; Bain, Peter G et al. (2016) Transducer-based evaluation of tremor. Mov Disord 31:1327-36
Simpson, David M; Hallett, Mark; Ashman, Eric J et al. (2016) Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 86:1818-26
Klein, Max M; Treister, Roi; Raij, Tommi et al. (2016) Reply. Pain 157:1175-6
Klein, Max M; Treister, Roi; Raij, Tommi et al. (2015) Transcranial magnetic stimulation of the brain: guidelines for pain treatment research. Pain 156:1601-14
Hallett, Mark (2015) Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them. Toxicon 107:64-7
Ferrazzano, Gina; Conte, Antonella; Fabbrini, Giovanni et al. (2014) Botulinum toxin and blink rate in patients with blepharospasm and increased blinking. J Neurol Neurosurg Psychiatry :

Showing the most recent 10 out of 39 publications